Adenocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Enrolling by invitation
  • Melanoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-01-13
    Jan 13, 2022
    C
    Active, not recruiting
    • Lung Neoplasms
    • +3 more
    • Sarasota, Florida
    • +19 more
    2022-01-11
    Jan 11, 2022
    C
    Recruiting
    • HER2-positive
    • +30 more
    • CT-0508
    • Duarte, California
    • +3 more
    2022-01-06
    Jan 6, 2022
    S
    Recruiting
    • Adenocarcinoma
    • +9 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    2022-01-04
    Jan 4, 2022
    N
    Enrolling by invitation
    • Adenocarcinoma
    • +4 more
    • EM Tracking
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-12-30
    Dec 30, 2021
    F
    Recruiting
    • Stomach Neoplasms
    • +7 more
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    2021-12-03
    Dec 3, 2021
    B
    Not yet recruiting
    • Lung Neoplasm
    • +26 more
    • (no location specified)
    2021-11-30
    Nov 30, 2021
    H
    Recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +78 more
    2021-12-08
    Dec 8, 2021
    M
    Active, not recruiting
    • Lung Neoplasms
    • +2 more
    • Multifocal Lung Adenocarcinoma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    2021-12-03
    Dec 3, 2021
    J
    Recruiting
    • Prostatic Neoplasms
    • Adenocarcinoma
    • Duarte, California
    • +6 more
    2021-12-02
    Dec 2, 2021
    B
    Recruiting
    • Lung Neoplasms
    • +23 more
    • Los Angeles, California
    • +10 more
    2021-11-30
    Nov 30, 2021
    O
    Not yet recruiting
    • Metastatic Cancer
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    2021-11-29
    Nov 29, 2021
    G
    Recruiting
    • Pancreatic Cancer
    • +2 more
    • New York, New York
    • +1 more
    2021-11-19
    Nov 19, 2021
    U
    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Aberdeen, United Kingdom
    • +24 more
    2021-11-02
    Nov 2, 2021
    H
    Recruiting
    • Gastric Cancer
    • +2 more
    • Pembrolizumab Monotherapy
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic- Minnesota
    2021-10-25
    Oct 25, 2021
    N
    Suspended
    • Advanced Non-Small Cell Lung Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-10-23
    Oct 23, 2021
    V
    Active, not recruiting
    • Adenocarcinoma
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    2021-10-19
    Oct 19, 2021
    T
    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
      Teton Cancer Institute
    2021-10-04
    Oct 4, 2021
    M
    Active, not recruiting
    • Esophageal Cancer
    • Adenocarcinoma
    • serum and tissue mesothelin
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-10-01
    Oct 1, 2021
    U
    Completed
    • Cancer
    • +3 more
    • esophagectomy with three-field lymphnode dissection
    • Utrecht, Netherlands
      UMC Utrecht
    2021-09-28
    Sep 28, 2021
    S
    Terminated
    • Breast Cancer
    • Adenocarcinoma
    • Eribulin mesilate
    • Aarau, Switzerland
    • +25 more
    2021-09-27
    Sep 27, 2021
    N
    Active, not recruiting
    • Adenocarcinoma
    • Prostate Cancer
    • Stereotactic Body Radiation Therapy
    • Lake Success, New York
      North Shore-LIJ Cancer Institute
    2021-08-30
    Aug 30, 2021